Product Code: ETC6186327 | Publication Date: Sep 2024 | Updated Date: Apr 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | Author: Shubham Deep | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The non-injectable insulin market in Australia is growing due to increased demand for alternative delivery methods. Oral, nasal, and transdermal insulin options are being developed to improve patient convenience and adherence. Regulatory approvals and technological advancements are supporting market expansion.
The non-injectable insulin market in Australia is growing due to increasing prevalence of diabetes and rising demand for alternative drug delivery methods. Growing adoption of oral insulin, nasal sprays, and inhalable insulin, along with increasing investment in drug delivery technologies, is driving market growth.
The non-injectable insulin market in Australia is constrained by high drug development costs and limited patient access to treatment. Regulatory requirements for drug approval and clinical trials increase operational complexity. Competition from alternative insulin delivery methods and limited government reimbursement options reduce market demand. High treatment costs and slow adoption of innovative therapies further restrict market growth.
The non-injectable insulin market in Australia is growing due to increasing demand for patient-friendly diabetes management solutions. Oral, inhalable, and transdermal insulin delivery methods are emerging as alternatives to traditional injections. Investment opportunities exist in developing improved drug formulations, expanding clinical trials for new delivery methods, and improving drug stability. Growth in the diabetic population and increased focus on patient convenience are driving market expansion.
The Australian government supports the availability of non-injectable insulin through the PBS, which covers the cost of innovative insulin delivery methods such as oral and inhalable insulin. The TGA ensures the rapid approval of new insulin products, while the NHMRC funds clinical trials to test the safety and efficacy of non-injectable insulin. The government also partners with pharmaceutical companies to reduce the cost of insulin products and improve patient access. Educational programs aimed at improving diabetes management encourage the adoption of new insulin delivery technologies.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Australia Non-Injectable Insulin Market Overview |
3.1 Australia Country Macro Economic Indicators |
3.2 Australia Non-Injectable Insulin Market Revenues & Volume, 2021 & 2031F |
3.3 Australia Non-Injectable Insulin Market - Industry Life Cycle |
3.4 Australia Non-Injectable Insulin Market - Porter's Five Forces |
3.5 Australia Non-Injectable Insulin Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.6 Australia Non-Injectable Insulin Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Australia Non-Injectable Insulin Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Australia Non-Injectable Insulin Market Trends |
6 Australia Non-Injectable Insulin Market, By Types |
6.1 Australia Non-Injectable Insulin Market, By Product |
6.1.1 Overview and Analysis |
6.1.2 Australia Non-Injectable Insulin Market Revenues & Volume, By Product, 2021- 2031F |
6.1.3 Australia Non-Injectable Insulin Market Revenues & Volume, By Pills, 2021- 2031F |
6.1.4 Australia Non-Injectable Insulin Market Revenues & Volume, By Sprays, 2021- 2031F |
6.1.5 Australia Non-Injectable Insulin Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Australia Non-Injectable Insulin Market, By Distribution Channel |
6.2.1 Overview and Analysis |
6.2.2 Australia Non-Injectable Insulin Market Revenues & Volume, By Hospital Pharmacies, 2021- 2031F |
6.2.3 Australia Non-Injectable Insulin Market Revenues & Volume, By Online Stores, 2021- 2031F |
6.2.4 Australia Non-Injectable Insulin Market Revenues & Volume, By Drug Stores, 2021- 2031F |
7 Australia Non-Injectable Insulin Market Import-Export Trade Statistics |
7.1 Australia Non-Injectable Insulin Market Export to Major Countries |
7.2 Australia Non-Injectable Insulin Market Imports from Major Countries |
8 Australia Non-Injectable Insulin Market Key Performance Indicators |
9 Australia Non-Injectable Insulin Market - Opportunity Assessment |
9.1 Australia Non-Injectable Insulin Market Opportunity Assessment, By Product, 2021 & 2031F |
9.2 Australia Non-Injectable Insulin Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Australia Non-Injectable Insulin Market - Competitive Landscape |
10.1 Australia Non-Injectable Insulin Market Revenue Share, By Companies, 2024 |
10.2 Australia Non-Injectable Insulin Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |